Agents such as TLR agonists (3M-052, CpG ODN), anti-CD40 antibodies, and low-dose metformin can induce M1 polarization, enhance macrophage and T-cell antitumor activity, and increase T-cell infiltration into the tumor microenvironment (102–105). This evidence concerns the gene CD40 and neoplasm.